Shareholders who lost money in shares of The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately
Shareholders who lost money in shares of The Ensign Group, Inc. (NASDAQ: ENSG) should contact Wolf Haldenstein Immediately
PR Newswire
NEW YORK, Oct. 15, 2026
Lead Plaintiff Deadline December 7, 2026
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG) on behalf of investors that purchased or otherwise acquired Ensign securities between February 10, 2022 and June 18, 2026 (the Class Period).
Investors who purchased Ensign shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for December 7, 2026.
PLEASE CLICK HERE TO SUBMIT CONTACT AND TRADE INFORMATION
A complaint has been filed against Ensign and certain executives alleging that Ensigns business model depends on the systematic and widespread neglect of elderly people who live in its facilities, including those with needs for high levels of care, that Ensign uses self-reporting measures as a way to cover up its systematic neglect of patients, defrauds Medicaid and Medicare, and has engaged in an illegal scheme, including the falsification of records.
According to the complaint, the truth began to emerge on June 8, 2026, when Hunterbrook Media published a report entitled Ensign: The Nursing Home Empire Built on Fatal Neglect. The report alleges that Ensign's business model relies on delivering inadequate care to patients while gaming data on quality, according to Hunterbrook's five-month investigation. The report further alleges former employees in different states described systematic misrepresentations.
Following this news, the price of Ensign stock fell $13.88 per share, or 8.15%, to close at $156.42 per share on June 8, 2026.
This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven record of protecting the rights of investors.
We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.
There is no cost or obligation to speak with an attorney.
Contact:
- Phone: (800) 575-0735 or (212) 545-4774
- Email: classmember@whafh.com
- Contact Person: Gregory Stone, Director of Case and Financial Analysis
Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
SOURCE Wolf Haldenstein Adler Freeman & Herz LLP
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
What’s Ahead for Stocks This Quarter—and Where to Invest
Are TIPS ETFs the Best Way to Fight Inflation?
10 Best Blue-Chip Stocks to Buy for the Long Term
This 1-Star Stock Trades at a 94% Premium. Is It Time to Sell?
United States